Related references
Note: Only part of the references are listed.Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
A. Michael Parfitt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Armed replicating adenoviruses for cancer virotherapy
J. J. Cody et al.
CANCER GENE THERAPY (2009)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis
Robert E. Miller et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Adenovirus serotype 5 hexon is critical for virus infection of heptocytes in vivo
O. Kalyuzhniy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis
Jude R. Canon et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice
S. Cowey et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd)
Rodney P. Rocconi et al.
GYNECOLOGIC ONCOLOGY (2007)
Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis
Yu Zheng et al.
BONE (2007)
The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice
S. H. Tannehill-Gregg et al.
CLINICAL & EXPERIMENTAL METASTASIS (2006)
Dynamic monitoring of oncolytic adenovirus in vivo by genetic capsid labeling
LP Le et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia
DWJ van der Schaft et al.
CANCER RESEARCH (2005)
Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region
HA Ono et al.
CANCER RESEARCH (2005)
Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo
AA Rivera et al.
VIROLOGY (2004)
A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity
TO Kirby et al.
CLINICAL CANCER RESEARCH (2004)
Common origins of MDA-MB-435 cells from various sources with those shown to have melonoma properties
JM Rae et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
A small molecule antagonist of the alpha(v)beta(3) integrin suppresses MDA-MB-435 skeletal metastasis
JF Harms et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
Lineage infidelity of MDA-MB-435 cells: Expression of melanocyte proteins in a breast cancer cell line
S Sellappan et al.
CANCER RESEARCH (2004)
Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor
M Anders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases
JJ Body et al.
CANCER (2003)
Mechanisms of osteolytic bone metastases in breast carcinoma
SM Käkönen et al.
CANCER (2003)
MDA-MB-435 human breast carcinoma metastasis to bone
JF Harms et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Establishment and characterization of osseous prostate cancer models: Intra tibial injection of human prostate cancer cells
E Corey et al.
PROSTATE (2002)
An in vivo model of prostate carcinoma growth and invasion in bone
JL Fisher et al.
CELL AND TISSUE RESEARCH (2002)
Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region
LK Hawkins et al.
GENE THERAPY (2001)
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone
J Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
D Kirn
GENE THERAPY (2001)
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
C Heise et al.
NATURE MEDICINE (2000)
Tartrate-resistant acid phosphatase 5b:: A novel serum marker of bone resorption
JM Halleen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Replicative adenoviruses for cancer therapy
R Alemany et al.
NATURE BIOTECHNOLOGY (2000)
Genetic targeting of adenoviral vectors
VN Krasnykh et al.
MOLECULAR THERAPY (2000)
Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer
T Hermiston
JOURNAL OF CLINICAL INVESTIGATION (2000)
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo et al.
ONCOGENE (2000)
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function
N Udagawa et al.
ENDOCRINOLOGY (2000)
Share Paper
